RACHEL HEWITT

Physician Assistants & Advanced Practice Nursing Providers|Nurse Practitioner LAFAYETTE, IN NPI 1255065686

General Payments — all program years on this page

$501.42

  • Category: General Payments
  • Program years: PY2023–2024
  • Record count: 28
  • As of (CMS publication): 2026-01-23

Latest program year (PY2024): $364.23 across 20 records · disputed records: 0

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How this figure is calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

Latest program year (PY2024) · sorted by reported total.

Nature of paymentAmountRecords
Food and Beverage $364.2320

By paying entity

Latest program year (PY2024) · sorted by reported total.

Paying entityAmountRecords
ABBVIE INC. $80.104
Novo Nordisk AS $64.214
GlaxoSmithKline, LLC. $61.693
Bayer HealthCare Pharmaceuticals Inc. $54.883
Acerta Pharma LLC $35.532
ITI, Inc. $34.182
Lilly USA, LLC $18.771
Amgen Inc. $14.871

By program year

Program yearAmountRecords
2023 $137.198
2024 $364.2320

Records — PY2024 (20)

Record IDPaying entityAmountDate Nature of paymentDispute statusPublishedSource
1086321684 Bayer Healthcare Pharmaceuticals Inc. $17.35 03/20/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1086333535 Bayer Healthcare Pharmaceuticals Inc. $22.88 09/04/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1086354844 Bayer Healthcare Pharmaceuticals Inc. $14.65 06/06/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1100344110 Novo Nordisk Inc $13.38 02/19/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1100399698 Novo Nordisk Inc $20.51 01/31/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1100643451 Novo Nordisk Inc $16.01 06/27/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1100654703 Novo Nordisk Inc $14.31 04/03/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1105847257 AstraZeneca Pharmaceuticals LP $15.50 04/18/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1105855624 AstraZeneca Pharmaceuticals LP $20.03 01/04/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1107329590 ABBVIE INC. $22.16 01/09/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1107329592 ABBVIE INC. $22.65 03/06/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1107329594 ABBVIE INC. $15.68 06/12/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1107329596 ABBVIE INC. $19.61 08/29/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1116407195 GlaxoSmithKline, LLC. $22.05 01/02/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1116520598 GlaxoSmithKline, LLC. $16.78 07/08/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1116542884 GlaxoSmithKline, LLC. $22.86 04/10/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1117578274 Amgen Inc. $14.87 03/11/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1135879070 Lilly USA, LLC $18.77 07/10/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1143492534 ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $16.02 01/17/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1143492540 ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $18.16 02/21/2024 Food and Beverage Undisputed 01/23/2026 View at CMS

Provenance & corrections

  • Dataset: CMS Open Payments — General Payments
  • Source: CMS Open Payments dataset (bulk file)
  • Publisher of source data: Centers for Medicare & Medicaid Services
  • Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.